Massachusetts Man Who Helped With Baby Raccoons May Need Rabies Treatment
CONCORD, N.H. (AP) — New Hampshire health officials are requesting the public’s help in finding a man from Massachusetts to assess his risk for rabies after he came into contact with baby raccoons.
Health officials say the man was in Conway at about 5 p.m. on Sept. 20 and stopped to help someone remove two baby raccoons on Route 16 between North Bald Hill Thorn Hill roads.
The raccoons were brought to a wildlife rehabilitation center, where one died and was identified to have rabies. The other didn’t have rabies.
Health officials said Friday the man, who drove a dark pickup truck with oversized tires and Mass...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - October 11, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Offbeat Syndicated CBSN Boston New Hampshire News Rabies raccoons Source Type: news
BayRab (Rabies Immune Globulin (Human) Solvent/Detergent Treated) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - August 9, 2019 Category: Drugs & Pharmacology Source Type: news
Xembify (Immune Globulin Subcutaneous, Human – klhw Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 30, 2019 Category: Drugs & Pharmacology Source Type: news
Xembify (Immune Globulin Subcutaneous, Human – klhw Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 11, 2019 Category: Drugs & Pharmacology Source Type: news
FDA OKs Immunoglobulin Xembify for Primary Immunodeficiencies FDA OKs Immunoglobulin Xembify for Primary Immunodeficiencies
Xembify is a 20% immune globulin solution for subcutaneous injection indicated to treat primary immunodeficiencies in patients aged 2 years and older.FDA Approvals (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - July 6, 2019 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Alert Source Type: news
FDA Approves Xembify (immune globulin subcutaneous) for Primary Immunodeficiencies
Barcelona, July 4, 2019.- Grifols, a leading global producer of plasma-derived medicines, announced today that Xembify, its new 20% subcutaneous immunoglobulin, has been approved by the U.S. Food and Drug Administration (FDA). Xembify is used to... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - July 4, 2019 Category: Drugs & Pharmacology Source Type: news
WinRho SDF ([Rh (D) Immune Globulin Intravenous (Human)] (WinRho SDF) Solution for Injection ) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - June 17, 2019 Category: Drugs & Pharmacology Source Type: news
Customers At Rockport Fish Shack May Have Been Exposed To Hepatitis A
ROCKPORT (CBS) – Officials at the Massachusetts Department of Public Health are warning customers of Ray Moore’s Fish Shack in Rockport that they may have been exposed to hepatitis A.
An employee who worked at the restaurant from April 21-May 12 has been diagnosed with hepatitis A.
Customers who dined during that time on cold or uncooked items such as salad, breads (including rolls and hot dog and hamburger buns), cold desserts, fruit or vegetable garnishes, condiments such as pickles and onions, chips and beverages containing ice should contact a doctor to receive treatment for possible exposure to hepatitis A...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 18, 2019 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Syndicated Local Hepatitis A Rockport News Source Type: news
Asceniv (Immune Globulin Intravenous, Human - slra for Injection) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 18, 2019 Category: Drugs & Pharmacology Source Type: news
Asceniv (Immune Globulin Intravenous, Human - slra for Injection) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - April 17, 2019 Category: Drugs & Pharmacology Source Type: news
FDA Approves Asceniv (immune globulin intravenous, human) for Primary Humoral Immunodeficiency
RAMSEY, N.J. and BOCA RATON, Fla., April 01, 2019 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (NASDAQ: ADMA) (“ADMA” or the“Company”), a vertically integrated commercial biopharmaceutical and specialty immunoglobulin company... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 1, 2019 Category: Drugs & Pharmacology Source Type: news
Anthrasil (Anthrax Immune Globulin Intravenous (Human), Sterile Solution for Infusion) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 28, 2019 Category: Drugs & Pharmacology Source Type: news
Anthrasil (Anthrax Immune Globulin Intravenous (Human), Sterile Solution for Infusion) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 27, 2019 Category: Drugs & Pharmacology Source Type: news
Update: Recommendations of the Advisory Committee on Immunization Practices for Use of Hepatitis A Vaccine for Postexposure Prophylaxis and for Preexposure Prophylaxis for International Travel
Postexposure prophylaxis with hepatitis A vaccine or immune globulin effectively prevents infection with hepatitis A virus when administered within 2 weeks of exposure. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - November 1, 2018 Category: American Health Tags: Hepatitis Hepatitis A MMWR Morbidity & Mortality Weekly Report Travelers' Health Vaccines Source Type: news
Vivaglobin (Immune Globulin Subcutaneous (Human)) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - September 14, 2018 Category: Drugs & Pharmacology Source Type: news
